[Federal Register Volume 67, Number 95 (Thursday, May 16, 2002)]
[Notices]
[Page 34936]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12231]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Announcement of 
Meeting and Request for Comments on Formulating Recommendations for the 
Use of Vaccinia (Smallpox) Vaccine

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-5:30 p.m., June 19, 2002.
    8 a.m.-3 p.m., June 20, 2002.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The Committee will discuss, among other 
items, the administration of vaccinia (smallpox) vaccine. Because of 
the considerable interest in the use of vaccinia (smallpox) vaccine, 
there will be a public comment period on the morning of June 19, not 
to exceed four hours, during which members of the public will be 
able to address the ACIP members on making recommendations for the 
use of vaccinia (smallpox) vaccine. Other topics to be discussed at 
the meeting include: a summary of the May 8-9 Smallpox Working Group 
meeting; update on CDC preparedness activities; public participation 
in formulating vaccine policy; update from the National Immunization 
Program, Food and Drug Administration, Vaccine Injury Compensation 
Program, National Institutes of Health, National Vaccine Program, 
and the National Center for Infectious Diseases; ACIP 
recommendations and influenza surveillance; Vaccines for Children 
vote on influenza vaccination of children 6-23 months; 
recommendations for mishandled vaccines; 2003 recommended childhood 
immunization schedule; recommended adult immunization schedule; 
update of vaccine supply; Institute of Medicine update on hepatitis 
B vaccine and neurological disorders; and combination DTaP-HepB-IPV 
vaccine.
    Agenda items are subject to change as priorities dictate.
    Anyone wishing to make an oral presentation should submit their 
request in writing, to the contact person by close of business June 
7, 2002. The request should include the name, address, and telephone 
number of the participant; the approximate time needed, and a copy 
of the presentation or a brief summary of the topic to be presented. 
Depending on the number of requests, up to 10 minutes will be 
allowed for each oral presentation. Anyone wishing to submit for 
consideration written comments regarding the use of vaccinia 
(smallpox) vaccine should submit the written comments to the contact 
person by June 14, 2002.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: May 9, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-12231 Filed 5-15-02; 8:45 am]
BILLING CODE 4163-18-P